Literature DB >> 28287260

Probing for and Quantifying Agonist Hydrogen Bonds in α6β2 Nicotinic Acetylcholine Receptors.

Michael R Post1, Henry A Lester1, Dennis A Dougherty1.   

Abstract

Designing subtype-selective agonists for neuronal nicotinic acetylcholine receptors is a challenging and significant goal aided by intricate knowledge of each subtype's binding patterns. We previously reported that in α6β2 receptors, acetylcholine makes a functional cation-π interaction with Trp149, but nicotine and TC299423 do not, suggesting a distinctive binding site. This work explores hydrogen binding at the backbone carbonyl associated with α6β2 Trp149. Substituting residue i + 1, Thr150, with its α-hydroxy analogue (Tah) attenuates the carbonyl's hydrogen bond accepting ability. At α6(T150Tah)β2, nicotine shows a 24-fold loss of function, TC299423 shows a modest loss, and acetylcholine shows no effect. Nicotine was further analyzed via a double-mutant cycle analysis utilizing N'-methylnicotinium, which indicated a hydrogen bond in α6β2 with a ΔΔG of 2.6 kcal/mol. Thus, even though nicotine does not make the conserved cation-π interaction with Trp149, it still makes a functional hydrogen bond to its associated backbone carbonyl.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28287260      PMCID: PMC6075822          DOI: 10.1021/acs.biochem.7b00213

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  33 in total

Review 1.  α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease.

Authors:  Maryka Quik; Susan Wonnacott
Journal:  Pharmacol Rev       Date:  2011-12       Impact factor: 25.468

Review 2.  Brain nicotinic acetylcholine receptors: native subtypes and their relevance.

Authors:  Cecilia Gotti; Michele Zoli; Francesco Clementi
Journal:  Trends Pharmacol Sci       Date:  2006-07-31       Impact factor: 14.819

Review 3.  Neuronal nicotinic acetylcholine receptors as targets for drug discovery.

Authors:  M W Holladay; M J Dart; J K Lynch
Journal:  J Med Chem       Date:  1997-12-19       Impact factor: 7.446

4.  X-ray structure of the mouse serotonin 5-HT3 receptor.

Authors:  Ghérici Hassaine; Cédric Deluz; Luigino Grasso; Romain Wyss; Menno B Tol; Ruud Hovius; Alexandra Graff; Henning Stahlberg; Takashi Tomizaki; Aline Desmyter; Christophe Moreau; Xiao-Dan Li; Frédéric Poitevin; Horst Vogel; Hugues Nury
Journal:  Nature       Date:  2014-08-03       Impact factor: 49.962

Review 5.  Striatal alpha6* nicotinic acetylcholine receptors: potential targets for Parkinson's disease therapy.

Authors:  Maryka Quik; J Michael McIntosh
Journal:  J Pharmacol Exp Ther       Date:  2005-10-06       Impact factor: 4.030

Review 6.  Diversity of native nicotinic receptor subtypes in mammalian brain.

Authors:  Michele Zoli; Francesco Pistillo; Cecilia Gotti
Journal:  Neuropharmacology       Date:  2014-11-25       Impact factor: 5.250

7.  Backbone mutations in transmembrane domains of a ligand-gated ion channel: implications for the mechanism of gating.

Authors:  P M England; Y Zhang; D A Dougherty; H A Lester
Journal:  Cell       Date:  1999-01-08       Impact factor: 41.582

8.  Crystal structure of a human GABAA receptor.

Authors:  Paul S Miller; A Radu Aricescu
Journal:  Nature       Date:  2014-06-08       Impact factor: 49.962

9.  Nicotine binding to brain receptors requires a strong cation-pi interaction.

Authors:  Xinan Xiu; Nyssa L Puskar; Jai A P Shanata; Henry A Lester; Dennis A Dougherty
Journal:  Nature       Date:  2009-03-01       Impact factor: 49.962

10.  X-ray structure of the human α4β2 nicotinic receptor.

Authors:  Claudio L Morales-Perez; Colleen M Noviello; Ryan E Hibbs
Journal:  Nature       Date:  2016-10-03       Impact factor: 49.962

View more
  2 in total

1.  TC299423, a Novel Agonist for Nicotinic Acetylcholine Receptors.

Authors:  Teagan R Wall; Brandon J Henderson; George Voren; Charles R Wageman; Purnima Deshpande; Bruce N Cohen; Sharon R Grady; Michael J Marks; Daniel Yohannes; Paul J Kenny; Merouane Bencherif; Henry A Lester
Journal:  Front Pharmacol       Date:  2017-09-26       Impact factor: 5.810

2.  Determining the pharmacokinetics of nicotinic drugs in the endoplasmic reticulum using biosensors.

Authors:  Amol V Shivange; Philip M Borden; Anand K Muthusamy; Aaron L Nichols; Kallol Bera; Huan Bao; Ishak Bishara; Janice Jeon; Matthew J Mulcahy; Bruce Cohen; Saidhbhe L O'Riordan; Charlene Kim; Dennis A Dougherty; Edwin R Chapman; Jonathan S Marvin; Loren L Looger; Henry A Lester
Journal:  J Gen Physiol       Date:  2019-02-04       Impact factor: 4.086

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.